Omeprazol Farmamabo (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Farmamabo, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Omeprazol Farmamabo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosive lesions and prevents recurrence. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess intestinal gas. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reactions. - Fracture risk: possible reduced bone density with long‑term use. - Liver enzyme elevation: abnormal hepatic function tests.

When using Omeprazol Farmamabo, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: long‑term therapy may lower magnesium. - Evaluate bone health: prolonged use may affect calcium balance. - Review concomitant medications: potential for altered absorption of drugs that require acidic pH. - Pregnancy and lactation: use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazole may interact with several medicines, requiring attention to the interaction severity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased plasma concentration. - Warfarin: potential increase in INR.

Moderate Interactions (Monitor Closely): - Digoxin: altered absorption may change serum levels. - Methotrexate: reduced renal clearance can raise toxicity risk. - Ketoconazole: decreased antifungal absorption. - Iron supplements: diminished iron uptake. - Vitamin B12: possible reduction in long‑term absorption.